Sign in

CIK 0001175151

  • Non-accelerated filer
  • Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980373793
Phone
+1 973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Grant or award Chief Operating Officer acquired 38,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 34,700 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 43,000 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Operating Officer gave up 35,257 shares (to pay taxes)
  5. 4 Open-market sale Chief Financial Officer sold 12,400 shares at $7.75 ($96,100)
  6. 4 Open-market sale Chief Financial Officer sold 32,400 shares at an average $7.30 ($236,400)
  7. 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.00 ($28,000)
  8. 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.04 ($10,100)
  9. 4 Open-market buy Director bought 1,500 shares at $4.12 ($6,180)
  10. 4 Open-market buy Chief Operating Officer bought 2,500 shares at $4.00 ($10,000)
  11. 4 Open-market buy President and CEO bought 3,700 shares at $4.00 ($14,800)
  12. 4 Open-market buy Director bought 2,500 shares at an average $3.99 ($9,987)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy President and CEO bought 6,300 shares at $4.00 ($25,200)
  15. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $4.34 ($4,341)
  16. 4 Grant or award Chief Operating Officer acquired 53,838 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 48,513 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 6,000 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 59,325 shares (grant or award)

Page 10 of 20 · 395 filings